nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—Latanoprost—glaucoma	0.53	1	CrCtD
Treprostinil—Latanoprost—Travoprost—glaucoma	0.0838	0.244	CrCrCtD
Treprostinil—Epoprostenol—Bimatoprost—glaucoma	0.0803	0.234	CrCrCtD
Treprostinil—Latanoprost—Bimatoprost—glaucoma	0.0694	0.202	CrCrCtD
Treprostinil—Nadolol—Carteolol—glaucoma	0.0551	0.16	CrCrCtD
Treprostinil—Nadolol—Levobunolol—glaucoma	0.0551	0.16	CrCrCtD
Treprostinil—CYP2C9—Diclofenamide—glaucoma	0.0117	0.354	CbGbCtD
Treprostinil—CYP2C9—Dorzolamide—glaucoma	0.0113	0.342	CbGbCtD
Treprostinil—CYP2C9—Methazolamide—glaucoma	0.0101	0.304	CbGbCtD
Treprostinil—PTGIR—Prostanoid ligand receptors—PTGFR—glaucoma	0.00302	0.122	CbGpPWpGaD
Treprostinil—Latanoprost—PTGFR—glaucoma	0.00218	1	CrCbGaD
Treprostinil—PTGIR—Eicosanoid ligand-binding receptors—PTGFR—glaucoma	0.00201	0.0808	CbGpPWpGaD
Treprostinil—PTGIR—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.00169	0.068	CbGpPWpGaD
Treprostinil—PTGIR—Small Ligand GPCRs—PTGFR—glaucoma	0.00166	0.0669	CbGpPWpGaD
Treprostinil—PTGIR—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.00115	0.0464	CbGpPWpGaD
Treprostinil—PTGIR—Endothelin Pathways—MYLK—glaucoma	0.000881	0.0355	CbGpPWpGaD
Treprostinil—PPARD—Ectoderm Differentiation—SIX6—glaucoma	0.000789	0.0318	CbGpPWpGaD
Treprostinil—PPARD—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—glaucoma	0.000583	0.0235	CbGpPWpGaD
Treprostinil—PPARD—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00047	0.0189	CbGpPWpGaD
Treprostinil—PTGIR—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000383	0.0154	CbGpPWpGaD
Treprostinil—PTGIR—Endothelin Pathways—EDN1—glaucoma	0.000355	0.0143	CbGpPWpGaD
Treprostinil—PPARD—Nuclear Receptors—NR3C1—glaucoma	0.000318	0.0128	CbGpPWpGaD
Treprostinil—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000301	0.0121	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—SLC6A13—glaucoma	0.000289	0.0116	CbGpPWpGaD
Treprostinil—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000274	0.011	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000272	0.0109	CbGpPWpGaD
Treprostinil—PPARD—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.000252	0.0101	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00025	0.0101	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000249	0.01	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—TXN—glaucoma	0.000237	0.00956	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000229	0.00922	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000224	0.00902	CbGpPWpGaD
Treprostinil—PTGIR—Endothelin Pathways—NOS3—glaucoma	0.000216	0.00871	CbGpPWpGaD
Treprostinil—PTGIR—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.000213	0.0086	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000213	0.00858	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—SLC6A1—glaucoma	0.000211	0.00852	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000206	0.0083	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000196	0.0079	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000192	0.00773	CbGpPWpGaD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—CCND2—glaucoma	0.000184	0.0074	CbGpPWpGaD
Treprostinil—PPARD—Ectoderm Differentiation—PAX6—glaucoma	0.000183	0.00738	CbGpPWpGaD
Treprostinil—PPARD—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.000177	0.00715	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000176	0.00711	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—TGFB2—glaucoma	0.000172	0.00695	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—OPN4—glaucoma	0.000162	0.00653	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—OPN4—glaucoma	0.000149	0.00601	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—PTGFR—glaucoma	0.000146	0.00588	CbGpPWpGaD
Treprostinil—PTGIR—Thromboxane A2 receptor signaling—NOS3—glaucoma	0.000142	0.00571	CbGpPWpGaD
Treprostinil—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	0.000139	0.0056	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—PTGFR—glaucoma	0.000134	0.00541	CbGpPWpGaD
Treprostinil—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	0.000124	0.005	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.000122	0.00493	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.00012	0.00484	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—NR3C1—glaucoma	0.000119	0.00479	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—GSTM1—glaucoma	0.000117	0.00472	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—FAS—glaucoma	0.000115	0.00464	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CA5A—glaucoma	0.000113	0.00456	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—NARFL—glaucoma	0.000113	0.00456	CbGpPWpGaD
Treprostinil—PTGIR—Platelet homeostasis—NOS3—glaucoma	0.000109	0.00438	CbGpPWpGaD
Treprostinil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	9.46e-05	0.00381	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—SOD1—glaucoma	9.28e-05	0.00374	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—OPN4—glaucoma	9.16e-05	0.00369	CbGpPWpGaD
Treprostinil—Nausea—Methazolamide—glaucoma	8.47e-05	0.00127	CcSEcCtD
Treprostinil—Hypotension—Dorzolamide—glaucoma	8.45e-05	0.00127	CcSEcCtD
Treprostinil—Dyspnoea—Brimonidine—glaucoma	8.44e-05	0.00127	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—OPN4—glaucoma	8.43e-05	0.0034	CbGpPWpGaD
Treprostinil—Hypotension—Travoprost—glaucoma	8.41e-05	0.00127	CcSEcCtD
Treprostinil—Shock—Pilocarpine—glaucoma	8.41e-05	0.00127	CcSEcCtD
Treprostinil—Rhinitis—Betaxolol—glaucoma	8.38e-05	0.00126	CcSEcCtD
Treprostinil—Thrombocytopenia—Pilocarpine—glaucoma	8.37e-05	0.00126	CcSEcCtD
Treprostinil—Erythema—Clonidine—glaucoma	8.36e-05	0.00126	CcSEcCtD
Treprostinil—Tachycardia—Pilocarpine—glaucoma	8.34e-05	0.00126	CcSEcCtD
Treprostinil—Dyspepsia—Brimonidine—glaucoma	8.34e-05	0.00125	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—OPN4—glaucoma	8.32e-05	0.00335	CbGpPWpGaD
Treprostinil—Hypotension—Brinzolamide—glaucoma	8.31e-05	0.00125	CcSEcCtD
Treprostinil—Pharyngitis—Betaxolol—glaucoma	8.3e-05	0.00125	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—PTGFR—glaucoma	8.25e-05	0.00332	CbGpPWpGaD
Treprostinil—Musculoskeletal discomfort—Dorzolamide—glaucoma	8.24e-05	0.00124	CcSEcCtD
Treprostinil—Tension—Clonidine—glaucoma	8.21e-05	0.00124	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Travoprost—glaucoma	8.2e-05	0.00124	CcSEcCtD
Treprostinil—Insomnia—Dorzolamide—glaucoma	8.18e-05	0.00123	CcSEcCtD
Treprostinil—Fatigue—Brimonidine—glaucoma	8.16e-05	0.00123	CcSEcCtD
Treprostinil—Anorexia—Pilocarpine—glaucoma	8.15e-05	0.00123	CcSEcCtD
Treprostinil—Feeling abnormal—Acetazolamide—glaucoma	8.13e-05	0.00122	CcSEcCtD
Treprostinil—Nervousness—Clonidine—glaucoma	8.12e-05	0.00122	CcSEcCtD
Treprostinil—Paraesthesia—Dorzolamide—glaucoma	8.12e-05	0.00122	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Brinzolamide—glaucoma	8.1e-05	0.00122	CcSEcCtD
Treprostinil—Pain—Brimonidine—glaucoma	8.1e-05	0.00122	CcSEcCtD
Treprostinil—Dyspnoea—Dorzolamide—glaucoma	8.06e-05	0.00121	CcSEcCtD
Treprostinil—Insomnia—Brinzolamide—glaucoma	8.04e-05	0.00121	CcSEcCtD
Treprostinil—Muscle spasms—Clonidine—glaucoma	8.04e-05	0.00121	CcSEcCtD
Treprostinil—Dyspnoea—Travoprost—glaucoma	8.03e-05	0.00121	CcSEcCtD
Treprostinil—Hypotension—Pilocarpine—glaucoma	7.99e-05	0.0012	CcSEcCtD
Treprostinil—Paraesthesia—Brinzolamide—glaucoma	7.98e-05	0.0012	CcSEcCtD
Treprostinil—Dyspepsia—Dorzolamide—glaucoma	7.96e-05	0.0012	CcSEcCtD
Treprostinil—Dyspnoea—Brinzolamide—glaucoma	7.93e-05	0.00119	CcSEcCtD
Treprostinil—Dyspepsia—Travoprost—glaucoma	7.93e-05	0.00119	CcSEcCtD
Treprostinil—Asthenia—Apraclonidine—glaucoma	7.91e-05	0.00119	CcSEcCtD
Treprostinil—Decreased appetite—Dorzolamide—glaucoma	7.86e-05	0.00118	CcSEcCtD
Treprostinil—Dyspepsia—Brinzolamide—glaucoma	7.83e-05	0.00118	CcSEcCtD
Treprostinil—Pruritus—Apraclonidine—glaucoma	7.8e-05	0.00117	CcSEcCtD
Treprostinil—Body temperature increased—Acetazolamide—glaucoma	7.8e-05	0.00117	CcSEcCtD
Treprostinil—Fatigue—Dorzolamide—glaucoma	7.8e-05	0.00117	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Pilocarpine—glaucoma	7.79e-05	0.00117	CcSEcCtD
Treprostinil—Fatigue—Travoprost—glaucoma	7.76e-05	0.00117	CcSEcCtD
Treprostinil—Flushing—Betaxolol—glaucoma	7.76e-05	0.00117	CcSEcCtD
Treprostinil—Ill-defined disorder—Clonidine—glaucoma	7.76e-05	0.00117	CcSEcCtD
Treprostinil—Pain—Dorzolamide—glaucoma	7.73e-05	0.00116	CcSEcCtD
Treprostinil—Insomnia—Pilocarpine—glaucoma	7.73e-05	0.00116	CcSEcCtD
Treprostinil—Decreased appetite—Brinzolamide—glaucoma	7.73e-05	0.00116	CcSEcCtD
Treprostinil—Pain—Travoprost—glaucoma	7.7e-05	0.00116	CcSEcCtD
Treprostinil—Paraesthesia—Pilocarpine—glaucoma	7.67e-05	0.00116	CcSEcCtD
Treprostinil—Asthenia—Bimatoprost—glaucoma	7.67e-05	0.00116	CcSEcCtD
Treprostinil—Fatigue—Brinzolamide—glaucoma	7.67e-05	0.00115	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—OPN4—glaucoma	7.66e-05	0.00309	CbGpPWpGaD
Treprostinil—Angioedema—Clonidine—glaucoma	7.64e-05	0.00115	CcSEcCtD
Treprostinil—Dyspnoea—Pilocarpine—glaucoma	7.62e-05	0.00115	CcSEcCtD
Treprostinil—Pain—Brinzolamide—glaucoma	7.6e-05	0.00114	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—PTGFR—glaucoma	7.59e-05	0.00306	CbGpPWpGaD
Treprostinil—Depression—Timolol—glaucoma	7.59e-05	0.00114	CcSEcCtD
Treprostinil—Pruritus—Bimatoprost—glaucoma	7.57e-05	0.00114	CcSEcCtD
Treprostinil—Diarrhoea—Apraclonidine—glaucoma	7.55e-05	0.00114	CcSEcCtD
Treprostinil—Malaise—Clonidine—glaucoma	7.54e-05	0.00114	CcSEcCtD
Treprostinil—Dyspepsia—Pilocarpine—glaucoma	7.52e-05	0.00113	CcSEcCtD
Treprostinil—Syncope—Clonidine—glaucoma	7.5e-05	0.00113	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—PTGFR—glaucoma	7.49e-05	0.00302	CbGpPWpGaD
Treprostinil—Feeling abnormal—Dorzolamide—glaucoma	7.45e-05	0.00112	CcSEcCtD
Treprostinil—Decreased appetite—Pilocarpine—glaucoma	7.43e-05	0.00112	CcSEcCtD
Treprostinil—Feeling abnormal—Travoprost—glaucoma	7.42e-05	0.00112	CcSEcCtD
Treprostinil—Gastrointestinal pain—Dorzolamide—glaucoma	7.4e-05	0.00111	CcSEcCtD
Treprostinil—Palpitations—Clonidine—glaucoma	7.39e-05	0.00111	CcSEcCtD
Treprostinil—Gastrointestinal pain—Travoprost—glaucoma	7.36e-05	0.00111	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—SMO—glaucoma	7.36e-05	0.00297	CbGpPWpGaD
Treprostinil—Loss of consciousness—Clonidine—glaucoma	7.35e-05	0.00111	CcSEcCtD
Treprostinil—Feeling abnormal—Brinzolamide—glaucoma	7.33e-05	0.0011	CcSEcCtD
Treprostinil—Pain—Pilocarpine—glaucoma	7.31e-05	0.0011	CcSEcCtD
Treprostinil—Cough—Clonidine—glaucoma	7.3e-05	0.0011	CcSEcCtD
Treprostinil—Dizziness—Apraclonidine—glaucoma	7.29e-05	0.0011	CcSEcCtD
Treprostinil—Erythema—Betaxolol—glaucoma	7.28e-05	0.0011	CcSEcCtD
Treprostinil—Epistaxis—Timolol—glaucoma	7.18e-05	0.00108	CcSEcCtD
Treprostinil—Abdominal pain—Dorzolamide—glaucoma	7.15e-05	0.00108	CcSEcCtD
Treprostinil—Body temperature increased—Dorzolamide—glaucoma	7.15e-05	0.00108	CcSEcCtD
Treprostinil—Tension—Betaxolol—glaucoma	7.14e-05	0.00108	CcSEcCtD
Treprostinil—Sinusitis—Timolol—glaucoma	7.14e-05	0.00107	CcSEcCtD
Treprostinil—Arthralgia—Clonidine—glaucoma	7.12e-05	0.00107	CcSEcCtD
Treprostinil—Chest pain—Clonidine—glaucoma	7.12e-05	0.00107	CcSEcCtD
Treprostinil—Abdominal pain—Travoprost—glaucoma	7.12e-05	0.00107	CcSEcCtD
Treprostinil—Anxiety—Clonidine—glaucoma	7.09e-05	0.00107	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—LRP12—glaucoma	7.09e-05	0.00286	CbGpPWpGaD
Treprostinil—Asthenia—Acetazolamide—glaucoma	7.08e-05	0.00107	CcSEcCtD
Treprostinil—Dizziness—Bimatoprost—glaucoma	7.07e-05	0.00106	CcSEcCtD
Treprostinil—Nervousness—Betaxolol—glaucoma	7.07e-05	0.00106	CcSEcCtD
Treprostinil—Feeling abnormal—Pilocarpine—glaucoma	7.04e-05	0.00106	CcSEcCtD
Treprostinil—Discomfort—Clonidine—glaucoma	7.03e-05	0.00106	CcSEcCtD
Treprostinil—Vomiting—Apraclonidine—glaucoma	7.01e-05	0.00106	CcSEcCtD
Treprostinil—P2RY12—G alpha (i) signalling events—C3—glaucoma	7e-05	0.00282	CbGpPWpGaD
Treprostinil—Muscle spasms—Betaxolol—glaucoma	7e-05	0.00105	CcSEcCtD
Treprostinil—Gastrointestinal pain—Pilocarpine—glaucoma	6.99e-05	0.00105	CcSEcCtD
Treprostinil—Bradycardia—Timolol—glaucoma	6.95e-05	0.00105	CcSEcCtD
Treprostinil—Dermatitis—Apraclonidine—glaucoma	6.95e-05	0.00105	CcSEcCtD
Treprostinil—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	6.95e-05	0.0028	CbGpPWpGaD
Treprostinil—Headache—Apraclonidine—glaucoma	6.91e-05	0.00104	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—PTGFR—glaucoma	6.9e-05	0.00278	CbGpPWpGaD
Treprostinil—Rhinitis—Timolol—glaucoma	6.85e-05	0.00103	CcSEcCtD
Treprostinil—Oedema—Clonidine—glaucoma	6.82e-05	0.00103	CcSEcCtD
Treprostinil—Asthenia—Brimonidine—glaucoma	6.79e-05	0.00102	CcSEcCtD
Treprostinil—Infection—Clonidine—glaucoma	6.78e-05	0.00102	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—SMO—glaucoma	6.78e-05	0.00273	CbGpPWpGaD
Treprostinil—Body temperature increased—Pilocarpine—glaucoma	6.76e-05	0.00102	CcSEcCtD
Treprostinil—Abdominal pain—Pilocarpine—glaucoma	6.76e-05	0.00102	CcSEcCtD
Treprostinil—Ill-defined disorder—Betaxolol—glaucoma	6.75e-05	0.00102	CcSEcCtD
Treprostinil—Diarrhoea—Acetazolamide—glaucoma	6.75e-05	0.00102	CcSEcCtD
Treprostinil—Rash—Bimatoprost—glaucoma	6.74e-05	0.00102	CcSEcCtD
Treprostinil—Dermatitis—Bimatoprost—glaucoma	6.74e-05	0.00101	CcSEcCtD
Treprostinil—Oedema peripheral—Timolol—glaucoma	6.73e-05	0.00101	CcSEcCtD
Treprostinil—Anaemia—Betaxolol—glaucoma	6.73e-05	0.00101	CcSEcCtD
Treprostinil—Shock—Clonidine—glaucoma	6.71e-05	0.00101	CcSEcCtD
Treprostinil—Pruritus—Brimonidine—glaucoma	6.7e-05	0.00101	CcSEcCtD
Treprostinil—Headache—Bimatoprost—glaucoma	6.7e-05	0.00101	CcSEcCtD
Treprostinil—Thrombocytopenia—Clonidine—glaucoma	6.68e-05	0.00101	CcSEcCtD
Treprostinil—Tachycardia—Clonidine—glaucoma	6.66e-05	0.001	CcSEcCtD
Treprostinil—Malaise—Betaxolol—glaucoma	6.56e-05	0.000988	CcSEcCtD
Treprostinil—Nausea—Apraclonidine—glaucoma	6.55e-05	0.000986	CcSEcCtD
Treprostinil—Syncope—Betaxolol—glaucoma	6.53e-05	0.000983	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—LRP12—glaucoma	6.53e-05	0.00263	CbGpPWpGaD
Treprostinil—Dizziness—Acetazolamide—glaucoma	6.52e-05	0.000982	CcSEcCtD
Treprostinil—Anorexia—Clonidine—glaucoma	6.51e-05	0.000979	CcSEcCtD
Treprostinil—Asthenia—Dorzolamide—glaucoma	6.49e-05	0.000977	CcSEcCtD
Treprostinil—Asthenia—Travoprost—glaucoma	6.46e-05	0.000973	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—FN1—glaucoma	6.46e-05	0.0026	CbGpPWpGaD
Treprostinil—Palpitations—Betaxolol—glaucoma	6.43e-05	0.000968	CcSEcCtD
Treprostinil—Pruritus—Dorzolamide—glaucoma	6.4e-05	0.000963	CcSEcCtD
Treprostinil—Loss of consciousness—Betaxolol—glaucoma	6.4e-05	0.000963	CcSEcCtD
Treprostinil—Asthenia—Brinzolamide—glaucoma	6.38e-05	0.00096	CcSEcCtD
Treprostinil—Hypotension—Clonidine—glaucoma	6.38e-05	0.00096	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	6.37e-05	0.00257	CbGpPWpGaD
Treprostinil—Pruritus—Travoprost—glaucoma	6.37e-05	0.000959	CcSEcCtD
Treprostinil—Cough—Betaxolol—glaucoma	6.35e-05	0.000956	CcSEcCtD
Treprostinil—Nausea—Bimatoprost—glaucoma	6.35e-05	0.000956	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—TGFB2—glaucoma	6.31e-05	0.00254	CbGpPWpGaD
Treprostinil—Pruritus—Brinzolamide—glaucoma	6.29e-05	0.000947	CcSEcCtD
Treprostinil—Vomiting—Acetazolamide—glaucoma	6.27e-05	0.000944	CcSEcCtD
Treprostinil—Dizziness—Brimonidine—glaucoma	6.26e-05	0.000943	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Clonidine—glaucoma	6.22e-05	0.000936	CcSEcCtD
Treprostinil—Chest pain—Betaxolol—glaucoma	6.2e-05	0.000933	CcSEcCtD
Treprostinil—Arthralgia—Betaxolol—glaucoma	6.2e-05	0.000933	CcSEcCtD
Treprostinil—Myalgia—Betaxolol—glaucoma	6.2e-05	0.000933	CcSEcCtD
Treprostinil—Diarrhoea—Dorzolamide—glaucoma	6.19e-05	0.000932	CcSEcCtD
Treprostinil—Headache—Acetazolamide—glaucoma	6.18e-05	0.00093	CcSEcCtD
Treprostinil—Anxiety—Betaxolol—glaucoma	6.18e-05	0.00093	CcSEcCtD
Treprostinil—Insomnia—Clonidine—glaucoma	6.17e-05	0.000929	CcSEcCtD
Treprostinil—Diarrhoea—Travoprost—glaucoma	6.16e-05	0.000927	CcSEcCtD
Treprostinil—Asthenia—Pilocarpine—glaucoma	6.13e-05	0.000923	CcSEcCtD
Treprostinil—Paraesthesia—Clonidine—glaucoma	6.13e-05	0.000922	CcSEcCtD
Treprostinil—Discomfort—Betaxolol—glaucoma	6.12e-05	0.000922	CcSEcCtD
Treprostinil—Dyspnoea—Clonidine—glaucoma	6.08e-05	0.000916	CcSEcCtD
Treprostinil—Diarrhoea—Brinzolamide—glaucoma	6.08e-05	0.000916	CcSEcCtD
Treprostinil—Pruritus—Pilocarpine—glaucoma	6.05e-05	0.00091	CcSEcCtD
Treprostinil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	6e-05	0.00242	CbGpPWpGaD
Treprostinil—Dizziness—Dorzolamide—glaucoma	5.98e-05	0.0009	CcSEcCtD
Treprostinil—Rash—Brimonidine—glaucoma	5.97e-05	0.000899	CcSEcCtD
Treprostinil—Dermatitis—Brimonidine—glaucoma	5.97e-05	0.000898	CcSEcCtD
Treprostinil—Dizziness—Travoprost—glaucoma	5.95e-05	0.000896	CcSEcCtD
Treprostinil—Erythema—Timolol—glaucoma	5.95e-05	0.000895	CcSEcCtD
Treprostinil—Oedema—Betaxolol—glaucoma	5.94e-05	0.000894	CcSEcCtD
Treprostinil—Headache—Brimonidine—glaucoma	5.93e-05	0.000893	CcSEcCtD
Treprostinil—Decreased appetite—Clonidine—glaucoma	5.93e-05	0.000893	CcSEcCtD
Treprostinil—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	5.92e-05	0.00239	CbGpPWpGaD
Treprostinil—Infection—Betaxolol—glaucoma	5.9e-05	0.000889	CcSEcCtD
Treprostinil—Fatigue—Clonidine—glaucoma	5.88e-05	0.000886	CcSEcCtD
Treprostinil—Dizziness—Brinzolamide—glaucoma	5.88e-05	0.000885	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	5.87e-05	0.00236	CbGpPWpGaD
Treprostinil—Nausea—Acetazolamide—glaucoma	5.86e-05	0.000882	CcSEcCtD
Treprostinil—Diarrhoea—Pilocarpine—glaucoma	5.85e-05	0.00088	CcSEcCtD
Treprostinil—Shock—Betaxolol—glaucoma	5.85e-05	0.00088	CcSEcCtD
Treprostinil—Tension—Timolol—glaucoma	5.84e-05	0.000879	CcSEcCtD
Treprostinil—Pain—Clonidine—glaucoma	5.84e-05	0.000879	CcSEcCtD
Treprostinil—Thrombocytopenia—Betaxolol—glaucoma	5.82e-05	0.000876	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—TGFB2—glaucoma	5.81e-05	0.00234	CbGpPWpGaD
Treprostinil—Tachycardia—Betaxolol—glaucoma	5.8e-05	0.000873	CcSEcCtD
Treprostinil—Nervousness—Timolol—glaucoma	5.78e-05	0.00087	CcSEcCtD
Treprostinil—Vomiting—Dorzolamide—glaucoma	5.75e-05	0.000866	CcSEcCtD
Treprostinil—Rash—Dorzolamide—glaucoma	5.7e-05	0.000858	CcSEcCtD
Treprostinil—Dermatitis—Dorzolamide—glaucoma	5.7e-05	0.000858	CcSEcCtD
Treprostinil—Rash—Travoprost—glaucoma	5.68e-05	0.000855	CcSEcCtD
Treprostinil—Dermatitis—Travoprost—glaucoma	5.67e-05	0.000854	CcSEcCtD
Treprostinil—Headache—Dorzolamide—glaucoma	5.67e-05	0.000853	CcSEcCtD
Treprostinil—Anorexia—Betaxolol—glaucoma	5.66e-05	0.000853	CcSEcCtD
Treprostinil—Vomiting—Brinzolamide—glaucoma	5.65e-05	0.000851	CcSEcCtD
Treprostinil—Dizziness—Pilocarpine—glaucoma	5.65e-05	0.000851	CcSEcCtD
Treprostinil—Headache—Travoprost—glaucoma	5.64e-05	0.000849	CcSEcCtD
Treprostinil—Nausea—Brimonidine—glaucoma	5.62e-05	0.000847	CcSEcCtD
Treprostinil—Feeling abnormal—Clonidine—glaucoma	5.62e-05	0.000847	CcSEcCtD
Treprostinil—Rash—Brinzolamide—glaucoma	5.61e-05	0.000844	CcSEcCtD
Treprostinil—Dermatitis—Brinzolamide—glaucoma	5.6e-05	0.000843	CcSEcCtD
Treprostinil—Gastrointestinal pain—Clonidine—glaucoma	5.58e-05	0.00084	CcSEcCtD
Treprostinil—Headache—Brinzolamide—glaucoma	5.57e-05	0.000838	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	5.57e-05	0.00224	CbGpPWpGaD
Treprostinil—Hypotension—Betaxolol—glaucoma	5.55e-05	0.000836	CcSEcCtD
Treprostinil—PPARD—Metabolism—CA1—glaucoma	5.52e-05	0.00223	CbGpPWpGaD
Treprostinil—Angioedema—Timolol—glaucoma	5.43e-05	0.000818	CcSEcCtD
Treprostinil—Vomiting—Pilocarpine—glaucoma	5.43e-05	0.000818	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Betaxolol—glaucoma	5.41e-05	0.000815	CcSEcCtD
Treprostinil—Abdominal pain—Clonidine—glaucoma	5.39e-05	0.000812	CcSEcCtD
Treprostinil—Body temperature increased—Clonidine—glaucoma	5.39e-05	0.000812	CcSEcCtD
Treprostinil—Rash—Pilocarpine—glaucoma	5.39e-05	0.000811	CcSEcCtD
Treprostinil—Dermatitis—Pilocarpine—glaucoma	5.38e-05	0.00081	CcSEcCtD
Treprostinil—Insomnia—Betaxolol—glaucoma	5.37e-05	0.000809	CcSEcCtD
Treprostinil—Nausea—Dorzolamide—glaucoma	5.37e-05	0.000809	CcSEcCtD
Treprostinil—Headache—Pilocarpine—glaucoma	5.35e-05	0.000806	CcSEcCtD
Treprostinil—Nausea—Travoprost—glaucoma	5.35e-05	0.000805	CcSEcCtD
Treprostinil—PPARD—Metabolism—CTSA—glaucoma	5.35e-05	0.00216	CbGpPWpGaD
Treprostinil—Paraesthesia—Betaxolol—glaucoma	5.33e-05	0.000803	CcSEcCtD
Treprostinil—Syncope—Timolol—glaucoma	5.33e-05	0.000803	CcSEcCtD
Treprostinil—Dyspnoea—Betaxolol—glaucoma	5.3e-05	0.000797	CcSEcCtD
Treprostinil—Nausea—Brinzolamide—glaucoma	5.28e-05	0.000795	CcSEcCtD
Treprostinil—Palpitations—Timolol—glaucoma	5.26e-05	0.000791	CcSEcCtD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—glaucoma	5.24e-05	0.00211	CbGpPWpGaD
Treprostinil—Dyspepsia—Betaxolol—glaucoma	5.23e-05	0.000787	CcSEcCtD
Treprostinil—Loss of consciousness—Timolol—glaucoma	5.23e-05	0.000787	CcSEcCtD
Treprostinil—Cough—Timolol—glaucoma	5.19e-05	0.000781	CcSEcCtD
Treprostinil—Decreased appetite—Betaxolol—glaucoma	5.16e-05	0.000777	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	5.12e-05	0.00206	CbGpPWpGaD
Treprostinil—Fatigue—Betaxolol—glaucoma	5.12e-05	0.000771	CcSEcCtD
Treprostinil—Pain—Betaxolol—glaucoma	5.08e-05	0.000765	CcSEcCtD
Treprostinil—Nausea—Pilocarpine—glaucoma	5.08e-05	0.000764	CcSEcCtD
Treprostinil—Arthralgia—Timolol—glaucoma	5.06e-05	0.000762	CcSEcCtD
Treprostinil—Chest pain—Timolol—glaucoma	5.06e-05	0.000762	CcSEcCtD
Treprostinil—Myalgia—Timolol—glaucoma	5.06e-05	0.000762	CcSEcCtD
Treprostinil—PPARD—Metabolism—CA2—glaucoma	5.05e-05	0.00204	CbGpPWpGaD
Treprostinil—Anxiety—Timolol—glaucoma	5.05e-05	0.00076	CcSEcCtD
Treprostinil—Discomfort—Timolol—glaucoma	5e-05	0.000753	CcSEcCtD
Treprostinil—PPARD—Generic Transcription Pathway—CDKN2B—glaucoma	4.95e-05	0.00199	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.94e-05	0.00199	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.94e-05	0.00199	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—OPN4—glaucoma	4.92e-05	0.00198	CbGpPWpGaD
Treprostinil—Asthenia—Clonidine—glaucoma	4.9e-05	0.000737	CcSEcCtD
Treprostinil—Feeling abnormal—Betaxolol—glaucoma	4.9e-05	0.000737	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—TNF—glaucoma	4.89e-05	0.00197	CbGpPWpGaD
Treprostinil—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.87e-05	0.00196	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—EDN1—glaucoma	4.85e-05	0.00196	CbGpPWpGaD
Treprostinil—Oedema—Timolol—glaucoma	4.85e-05	0.000731	CcSEcCtD
Treprostinil—Pruritus—Clonidine—glaucoma	4.83e-05	0.000727	CcSEcCtD
Treprostinil—Infection—Timolol—glaucoma	4.82e-05	0.000726	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—SOD1—glaucoma	4.78e-05	0.00193	CbGpPWpGaD
Treprostinil—Shock—Timolol—glaucoma	4.78e-05	0.000719	CcSEcCtD
Treprostinil—Body temperature increased—Betaxolol—glaucoma	4.7e-05	0.000707	CcSEcCtD
Treprostinil—Diarrhoea—Clonidine—glaucoma	4.67e-05	0.000703	CcSEcCtD
Treprostinil—Anorexia—Timolol—glaucoma	4.63e-05	0.000696	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—HEYL—glaucoma	4.57e-05	0.00184	CbGpPWpGaD
Treprostinil—Hypotension—Timolol—glaucoma	4.54e-05	0.000683	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—OPN4—glaucoma	4.52e-05	0.00182	CbGpPWpGaD
Treprostinil—Dizziness—Clonidine—glaucoma	4.51e-05	0.000679	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—EDN1—glaucoma	4.47e-05	0.0018	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTGFR—glaucoma	4.43e-05	0.00178	CbGpPWpGaD
Treprostinil—Musculoskeletal discomfort—Timolol—glaucoma	4.42e-05	0.000666	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—SOD1—glaucoma	4.4e-05	0.00177	CbGpPWpGaD
Treprostinil—Insomnia—Timolol—glaucoma	4.39e-05	0.000661	CcSEcCtD
Treprostinil—Paraesthesia—Timolol—glaucoma	4.36e-05	0.000656	CcSEcCtD
Treprostinil—PPARD—Generic Transcription Pathway—NR3C1—glaucoma	4.34e-05	0.00175	CbGpPWpGaD
Treprostinil—Vomiting—Clonidine—glaucoma	4.34e-05	0.000653	CcSEcCtD
Treprostinil—Dyspnoea—Timolol—glaucoma	4.33e-05	0.000651	CcSEcCtD
Treprostinil—Rash—Clonidine—glaucoma	4.3e-05	0.000648	CcSEcCtD
Treprostinil—Dermatitis—Clonidine—glaucoma	4.3e-05	0.000647	CcSEcCtD
Treprostinil—Headache—Clonidine—glaucoma	4.28e-05	0.000644	CcSEcCtD
Treprostinil—Dyspepsia—Timolol—glaucoma	4.27e-05	0.000643	CcSEcCtD
Treprostinil—Asthenia—Betaxolol—glaucoma	4.26e-05	0.000642	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—C3—glaucoma	4.24e-05	0.00171	CbGpPWpGaD
Treprostinil—Decreased appetite—Timolol—glaucoma	4.22e-05	0.000635	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—HEYL—glaucoma	4.21e-05	0.00169	CbGpPWpGaD
Treprostinil—Pruritus—Betaxolol—glaucoma	4.2e-05	0.000633	CcSEcCtD
Treprostinil—Fatigue—Timolol—glaucoma	4.18e-05	0.00063	CcSEcCtD
Treprostinil—Pain—Timolol—glaucoma	4.15e-05	0.000625	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—PTGFR—glaucoma	4.07e-05	0.00164	CbGpPWpGaD
Treprostinil—Diarrhoea—Betaxolol—glaucoma	4.07e-05	0.000612	CcSEcCtD
Treprostinil—Nausea—Clonidine—glaucoma	4.05e-05	0.00061	CcSEcCtD
Treprostinil—Feeling abnormal—Timolol—glaucoma	4e-05	0.000602	CcSEcCtD
Treprostinil—Gastrointestinal pain—Timolol—glaucoma	3.97e-05	0.000597	CcSEcCtD
Treprostinil—Dizziness—Betaxolol—glaucoma	3.93e-05	0.000591	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—C3—glaucoma	3.9e-05	0.00157	CbGpPWpGaD
Treprostinil—Abdominal pain—Timolol—glaucoma	3.84e-05	0.000578	CcSEcCtD
Treprostinil—Body temperature increased—Timolol—glaucoma	3.84e-05	0.000578	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—SMO—glaucoma	3.78e-05	0.00152	CbGpPWpGaD
Treprostinil—Vomiting—Betaxolol—glaucoma	3.78e-05	0.000569	CcSEcCtD
Treprostinil—Rash—Betaxolol—glaucoma	3.75e-05	0.000564	CcSEcCtD
Treprostinil—Dermatitis—Betaxolol—glaucoma	3.74e-05	0.000563	CcSEcCtD
Treprostinil—Headache—Betaxolol—glaucoma	3.72e-05	0.00056	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—VEGFA—glaucoma	3.7e-05	0.00149	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—MMP1—glaucoma	3.65e-05	0.00147	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—TXN—glaucoma	3.56e-05	0.00143	CbGpPWpGaD
Treprostinil—Nausea—Betaxolol—glaucoma	3.53e-05	0.000531	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—CAV1—glaucoma	3.5e-05	0.00141	CbGpPWpGaD
Treprostinil—Asthenia—Timolol—glaucoma	3.48e-05	0.000524	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—SMO—glaucoma	3.48e-05	0.0014	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RPTOR—glaucoma	3.46e-05	0.0014	CbGpPWpGaD
Treprostinil—Pruritus—Timolol—glaucoma	3.43e-05	0.000517	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—MMP1—glaucoma	3.36e-05	0.00135	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NCK2—glaucoma	3.35e-05	0.00135	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—FN1—glaucoma	3.33e-05	0.00134	CbGpPWpGaD
Treprostinil—Diarrhoea—Timolol—glaucoma	3.32e-05	0.0005	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.25e-05	0.00131	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—GSTT1—glaucoma	3.24e-05	0.00131	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—CAV1—glaucoma	3.22e-05	0.0013	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.22e-05	0.0013	CbGpPWpGaD
Treprostinil—Dizziness—Timolol—glaucoma	3.21e-05	0.000483	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—RPTOR—glaucoma	3.19e-05	0.00128	CbGpPWpGaD
Treprostinil—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	3.13e-05	0.00126	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NCK2—glaucoma	3.09e-05	0.00124	CbGpPWpGaD
Treprostinil—Vomiting—Timolol—glaucoma	3.09e-05	0.000465	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—FN1—glaucoma	3.06e-05	0.00123	CbGpPWpGaD
Treprostinil—Rash—Timolol—glaucoma	3.06e-05	0.000461	CcSEcCtD
Treprostinil—Dermatitis—Timolol—glaucoma	3.06e-05	0.00046	CcSEcCtD
Treprostinil—Headache—Timolol—glaucoma	3.04e-05	0.000458	CcSEcCtD
Treprostinil—Nausea—Timolol—glaucoma	2.88e-05	0.000434	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—HDAC9—glaucoma	2.85e-05	0.00115	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GSTT1—glaucoma	2.76e-05	0.00111	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—EDN1—glaucoma	2.74e-05	0.00111	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—NOS3—glaucoma	2.64e-05	0.00107	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HDAC9—glaucoma	2.62e-05	0.00106	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—CYP1B1—glaucoma	2.59e-05	0.00104	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	2.55e-05	0.00103	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—EDN1—glaucoma	2.52e-05	0.00102	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—EDN1—glaucoma	2.49e-05	0.001	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—NOS3—glaucoma	2.43e-05	0.000981	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.41e-05	0.000973	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—C3—glaucoma	2.4e-05	0.000965	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—CDKN2B—glaucoma	2.38e-05	0.00096	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—EDN1—glaucoma	2.29e-05	0.000924	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CA5A—glaucoma	2.27e-05	0.000916	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NARFL—glaucoma	2.27e-05	0.000916	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SMO—glaucoma	2.23e-05	0.000899	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.22e-05	0.000896	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—C3—glaucoma	2.21e-05	0.000889	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ABCA1—glaucoma	2.2e-05	0.000886	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CYP1B1—glaucoma	2.2e-05	0.000886	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—C3—glaucoma	2.18e-05	0.000877	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—NR3C1—glaucoma	2.09e-05	0.000843	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—GSTM1—glaucoma	2.07e-05	0.000833	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SMO—glaucoma	2.05e-05	0.000828	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NTRK2—glaucoma	2.04e-05	0.000822	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	2.04e-05	0.000821	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—C3—glaucoma	2e-05	0.000807	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—VEGFA—glaucoma	1.91e-05	0.000768	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NTRK2—glaucoma	1.88e-05	0.000757	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GSTM1—glaucoma	1.76e-05	0.000708	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VEGFA—glaucoma	1.75e-05	0.000706	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NGFR—glaucoma	1.75e-05	0.000706	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NTRK1—glaucoma	1.66e-05	0.00067	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NGFR—glaucoma	1.61e-05	0.000649	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—MTHFR—glaucoma	1.55e-05	0.000626	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CDKN2B—glaucoma	1.53e-05	0.000618	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NTRK1—glaucoma	1.53e-05	0.000617	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EDN1—glaucoma	1.47e-05	0.000593	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—APOE—glaucoma	1.45e-05	0.000583	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TP53—glaucoma	1.44e-05	0.00058	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CAV1—glaucoma	1.43e-05	0.000577	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDKN2B—glaucoma	1.41e-05	0.000569	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EDN1—glaucoma	1.35e-05	0.000546	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NGF—glaucoma	1.35e-05	0.000545	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TP53—glaucoma	1.32e-05	0.000534	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—C3—glaucoma	1.29e-05	0.000518	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NGF—glaucoma	1.24e-05	0.000501	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APOE—glaucoma	1.2e-05	0.000482	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CAV1—glaucoma	1.19e-05	0.000478	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—C3—glaucoma	1.18e-05	0.000477	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FN1—glaucoma	1.13e-05	0.000455	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—BAD—glaucoma	1.12e-05	0.000449	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CA1—glaucoma	1.11e-05	0.000447	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOE—glaucoma	1.1e-05	0.000444	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CAV1—glaucoma	1.09e-05	0.00044	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—NOS3—glaucoma	1.08e-05	0.000437	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CTSA—glaucoma	1.08e-05	0.000433	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FN1—glaucoma	1.04e-05	0.000418	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—BAD—glaucoma	1.03e-05	0.000414	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CA2—glaucoma	1.02e-05	0.000409	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	9.93e-06	0.0004	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	9.93e-06	0.0004	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTGS2—glaucoma	9.91e-06	0.000399	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NOS3—glaucoma	8.97e-06	0.000361	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NOS3—glaucoma	8.25e-06	0.000332	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CDKN1B—glaucoma	7.77e-06	0.000313	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MMP9—glaucoma	7.19e-06	0.00029	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TXN—glaucoma	7.16e-06	0.000288	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDKN1B—glaucoma	7.15e-06	0.000288	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP9—glaucoma	6.62e-06	0.000267	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	6.53e-06	0.000263	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	6.47e-06	0.000261	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—glaucoma	6.46e-06	0.00026	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—glaucoma	5.94e-06	0.00024	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTT1—glaucoma	5.55e-06	0.000224	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TP53—glaucoma	4.88e-06	0.000197	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TP53—glaucoma	4.49e-06	0.000181	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.47e-06	0.00018	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCA1—glaucoma	4.42e-06	0.000178	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP1B1—glaucoma	4.42e-06	0.000178	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTM1—glaucoma	3.53e-06	0.000142	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MTHFR—glaucoma	3.12e-06	0.000126	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOE—glaucoma	2.91e-06	0.000117	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CAV1—glaucoma	2.88e-06	0.000116	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NOS3—glaucoma	2.18e-06	8.78e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTGS2—glaucoma	1.99e-06	8.03e-05	CbGpPWpGaD
